Work

Cystamine increases l ‐cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation

Year: 2004

Type: article

Source: Journal of Neurochemistry

DOI: 10.1111/j.1471-4159.2004.02726.x

Authors: Jonathan H. Fox, David S. Barber, Bhupinder Singh, Birgit Zucker, Mary K. Swindell, Fran Norflus, Rodica Buzescu, Raman Chopra, Robert J. Ferrante, Aleksey Kazantsev, Steven M. Hersch

Institutions: Massachusetts General Hospital, University of Florida, Boston University, Edith Nourse Rogers Memorial Veterans Hospital

Language: English

Topic: Genetic Neurodegenerative Diseases

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Institute on Aging, National Institute of Neurological Disorders and Stroke, National Center for Complementary and Integrative Health

Awards: G1064289161, G1856555311, Combination Drug Therapy in Huntington's Disease, G1964600565, G2466425206, G2530945350, Transcription and Therapy for HD: from Molecules to Man, G3460930458, HUNTINGTON PROTEIN AND THE HUNTINGTON'S DISEASE MUTATION, Boston University Alzheimer's Disease Center, OXIDATIVE AND EXCITATORY TOXICITY IN NEURODEGENERATION

OpenAlex ID: W2054749434

FWCI: 2.581

Cites: 48

Cited by: 124

Related to: 10